Philips launches IntelliSpace upgrades at HIMSS
Royal Philips has launched the next generation of its IntelliSpace cardiovascular...Read more on AuntMinnie.comRelated Reading: Philips launches operational IT application Philips to open new Ohio R&D facility for CT Philips signs Middle East EMR deal Philips taps Rocha as new North America CEO Royal Philips acquires IT firm Forcare
CONCLUSION: One copy number of GSTM1 and GSTT1 presented a higher frequency among carrier genes, but the CNV of GSTM1 and GSTT1 was not associated with HNC risk. PMID: 30526121 [PubMed - as supplied by publisher]
Check-Cap is getting one step closer to having its capsule-based screening method for colorectal cancer on the U.S. market. The Isfiya, Israel-based company has received FDA conditional approval for an IDE to initiate a pilot study of the C-Scan capsule. FDAâs conditional approval of the IDE requires Check-Cap to provide additional information to the agency and the company may begin enrolling patients immediately upon approval by the study site's Institutional Review Board (IRB). The trial will consist of up to 45 patients and it will be a single-arm study. Patients who are enrolled will be those conside...